VOYA Investment Management
CADX

VOYA Investment Management’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

VOYA Investment Management’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-59,122
Closed -$535K – 2552
2013
Q4 		$535K Hold
59,122
– – ﹤0.01% 1911
2013
Q3 		$373K Hold
59,122
– – ﹤0.01% 2141
2013
Q2 		$403K Buy
+59,122
New +$412K ﹤0.01% 2012

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

VOYA Investment Management's CADX Position: Q1 2014 in Review

VOYA Investment Management sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 59,122 shares — an estimated $535K sold.

VOYA Investment Management first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $535K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • VOYA Investment Management reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • VOYA Investment Management sold 59,122 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $535K.
  • VOYA Investment Management first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • VOYA Investment Management's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $535K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on VOYA Investment Management's 13F filing for Q1 2014, filed 15 May 2014.